Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations

This study aims to compare the efficacy of antiseptic dressings, hyperbaric oxygen therapy, and recombinant human platelet derived growth factor (rhPDGF) for two reasons: i) to reduce the incidence of lower limb amputations in diabetic foot ulcer; ii) to limit the duration of stay in the hospital. A...

Full description

Bibliographic Details
Main Authors: Poras Chaudhary, Sachin Khandelwal, Dev Datta Poddar, Neeraj Saxena, Rana A.K. Singh, Upendra C. Biswal
Format: Article
Language:English
Published: MDPI AG 2013-02-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.clinicsandpractice.org/index.php/cp/article/view/558
_version_ 1811186625538949120
author Poras Chaudhary
Sachin Khandelwal
Dev Datta Poddar
Neeraj Saxena
Rana A.K. Singh
Upendra C. Biswal
author_facet Poras Chaudhary
Sachin Khandelwal
Dev Datta Poddar
Neeraj Saxena
Rana A.K. Singh
Upendra C. Biswal
author_sort Poras Chaudhary
collection DOAJ
description This study aims to compare the efficacy of antiseptic dressings, hyperbaric oxygen therapy, and recombinant human platelet derived growth factor (rhPDGF) for two reasons: i) to reduce the incidence of lower limb amputations in diabetic foot ulcer; ii) to limit the duration of stay in the hospital. A prospective randomized trial was conducted on 60 patients with stage III and IV diabetic foot ulcers (International Association of Enterostomal Therapy classification) and patients were divided randomly in three different therapy groups - antiseptics, hyperbaric oxygen therapy, recombinant platelet derived growth factor, with 20 patients in each group. Patients were managed initially on inpatient and then on outpatient basis till the ulcer healed completely. Results among three groups were compared using unpaired T test and the level of significance was set at P<0.05 using ANOVA. This study compares the efficacy of hyperbaric oxygen therapy, antiseptic dressings, and rhPDGF in grade III and IV diabetic foot ulcers. P value (0.0348) was significant for complete wound contraction while p value healing time (0.6534) and ulcer size (0.0593) in the groups was not significant. PDGF is safe, effective and easy to apply. Results are comparable with hyperbaric oxygen (HBO) therapy and cost of treatment is lower than other therapies. Diabetic foot ulcer management requires multidisciplinary and aggressive approach. PDGF should be recommended for all grade III and IV diabetic foot ulcer at least 8 weeks old. HBO is equally good an option but has limitations and side effects.
first_indexed 2024-04-11T13:48:30Z
format Article
id doaj.art-77c78aed60414b378b97d9ba62c532d0
institution Directory Open Access Journal
issn 2039-7275
2039-7283
language English
last_indexed 2024-04-11T13:48:30Z
publishDate 2013-02-01
publisher MDPI AG
record_format Article
series Clinics and Practice
spelling doaj.art-77c78aed60414b378b97d9ba62c532d02022-12-22T04:20:49ZengMDPI AGClinics and Practice2039-72752039-72832013-02-013110.4081/cp.2013.e9234Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputationsPoras Chaudhary0Sachin Khandelwal1Dev Datta Poddar2Neeraj Saxena3Rana A.K. Singh4Upendra C. Biswal5Dr Ram Manohar Lohia Hospital and PGIMER, New DelhiDr Ram Manohar Lohia Hospital and PGIMER, New DelhiDr Ram Manohar Lohia Hospital and PGIMER, New DelhiDr Ram Manohar Lohia Hospital and PGIMER, New DelhiDr Ram Manohar Lohia Hospital and PGIMER, New DelhiDr Ram Manohar Lohia Hospital and PGIMER, New DelhiThis study aims to compare the efficacy of antiseptic dressings, hyperbaric oxygen therapy, and recombinant human platelet derived growth factor (rhPDGF) for two reasons: i) to reduce the incidence of lower limb amputations in diabetic foot ulcer; ii) to limit the duration of stay in the hospital. A prospective randomized trial was conducted on 60 patients with stage III and IV diabetic foot ulcers (International Association of Enterostomal Therapy classification) and patients were divided randomly in three different therapy groups - antiseptics, hyperbaric oxygen therapy, recombinant platelet derived growth factor, with 20 patients in each group. Patients were managed initially on inpatient and then on outpatient basis till the ulcer healed completely. Results among three groups were compared using unpaired T test and the level of significance was set at P<0.05 using ANOVA. This study compares the efficacy of hyperbaric oxygen therapy, antiseptic dressings, and rhPDGF in grade III and IV diabetic foot ulcers. P value (0.0348) was significant for complete wound contraction while p value healing time (0.6534) and ulcer size (0.0593) in the groups was not significant. PDGF is safe, effective and easy to apply. Results are comparable with hyperbaric oxygen (HBO) therapy and cost of treatment is lower than other therapies. Diabetic foot ulcer management requires multidisciplinary and aggressive approach. PDGF should be recommended for all grade III and IV diabetic foot ulcer at least 8 weeks old. HBO is equally good an option but has limitations and side effects.https://www.clinicsandpractice.org/index.php/cp/article/view/558diabetic foot ulcersantiseptic dressinghyperbaric oxygen therapyplatelet derived growth factor gel.
spellingShingle Poras Chaudhary
Sachin Khandelwal
Dev Datta Poddar
Neeraj Saxena
Rana A.K. Singh
Upendra C. Biswal
Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations
Clinics and Practice
diabetic foot ulcers
antiseptic dressing
hyperbaric oxygen therapy
platelet derived growth factor gel.
title Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations
title_full Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations
title_fullStr Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations
title_full_unstemmed Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations
title_short Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations
title_sort comparative study of different treatment options of grade iii and iv diabetic foot ulcers to reduce the incidence of amputations
topic diabetic foot ulcers
antiseptic dressing
hyperbaric oxygen therapy
platelet derived growth factor gel.
url https://www.clinicsandpractice.org/index.php/cp/article/view/558
work_keys_str_mv AT poraschaudhary comparativestudyofdifferenttreatmentoptionsofgradeiiiandivdiabeticfootulcerstoreducetheincidenceofamputations
AT sachinkhandelwal comparativestudyofdifferenttreatmentoptionsofgradeiiiandivdiabeticfootulcerstoreducetheincidenceofamputations
AT devdattapoddar comparativestudyofdifferenttreatmentoptionsofgradeiiiandivdiabeticfootulcerstoreducetheincidenceofamputations
AT neerajsaxena comparativestudyofdifferenttreatmentoptionsofgradeiiiandivdiabeticfootulcerstoreducetheincidenceofamputations
AT ranaaksingh comparativestudyofdifferenttreatmentoptionsofgradeiiiandivdiabeticfootulcerstoreducetheincidenceofamputations
AT upendracbiswal comparativestudyofdifferenttreatmentoptionsofgradeiiiandivdiabeticfootulcerstoreducetheincidenceofamputations